Search Within

Daniel C. McFarland

  1. "Body Imaging Service"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Body Imaging Service (6)
  2. Department of Medicine (6)
  3. Radiology, Department of (6)
  4. Solid Tumor Oncology Division (6)
  5. Thoracic Oncology (6)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)

More Groups

People
  1. Charles Rudin (5)
  2. Linda Ahn (5)
  3. Paul Paik (5)
  4. Juliana Eng (4)
  5. Afsheen Iqbal (3)
  6. Andrew Plodkowski (3)

More People

Years
  1. 2021 (1)
  2. 2020 (1)
  3. 2018 (4)
Publications
  1. Journal of Clinical Oncology (3)
  2. Journal of Thoracic Oncology (2)
  3. Clinical Cancer Research (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Elsevier Inc. (2)
  3. American Association for Cancer Research (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase II trial of nivolumab with stereotactic body radiotherapy versus nivolumab alone in metastatic head and neck squamous cell carcinoma
    Journal Article

    McBride, S.; Sherman, E.; Tsai, C. J.; Baxi, S.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D.; Michel, L. S.; Young, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed stage IV squamous cell lung cancers
    Journal Article

    Paik, P. K.; Kim, R. K.; Ahn, L.; Plodkowski, A. J.; Ni, A.; Donoghue, M. T. A.; Jonsson, P.; Villalona-Calero, M.; Ng, K.; McFarland, D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed PD-L1 IHC low/unknown stage IV squamous cell lung cancers
    Meeting Abstract

    Paik, P. K.; Srikakulum, A.; Ahn, L. S. H.; Plodkowski, A. J.; Ng, K. K.; McFarland, D.; Fiore, J. J.; Iqbal, A.; Eng, J.; Rudin, C. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Targeting NFE2L2 mutations in advanced squamous cell lung cancers with the TORC1/2 inhibitor TAK228
    Meeting Abstract

    Paik, P. K.; Qeriqi, B.; Ahn, L. S. H.; Ginsberg, M. S.; Tandon, N.; McFarland, D.; Doyle, L. A.; de Stanchina, E.; Rudin, C. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Targeting NFE2L2 mutations in advanced squamous cell lung cancers with the TORC1/2 inhibitor TAK-228
    Meeting Abstract

    Paik, P.; Ahn, L.; Ginsberg, M.; McFarland, D.; Doyle, L.; Rudin, C.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed stage IV squamous cell lung cancers
    Meeting Abstract

    Paik, P.; Kim, R.; Ahn, L.; Plodkowski, A.; Ng, K.; McFarland, D.; Iqbal, A.; Eng, J.; Rudin, C.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save